stockportfolio.pro
Stocks / MTD vs WST
MTD vs WST
Mettler-Toledo International Inc. and West Pharmaceutical Services, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Mettler-Toledo International Inc. (MTD) | West Pharmaceutical Services, Inc. (WST) | |
|---|---|---|
| Market cap | $23.5B | $23.6B |
| Revenue (latest FY) | $4.03B | $3.07B |
| Net income (latest FY) | $869.19M | $493.70M |
| Revenue growth (5y CAGR) | 5.5% | 7.4% |
| Net margin | 21.6% | 16.1% |
| Return on equity | -3677.4% | 15.5% |
| P/E ratio | 27.3 | 44.7 |
| Dividend yield | — | 0.3% |
| Profitable years (of last 10) | 10 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open MTD — free Open WST — freeFrequently asked questions
Which is bigger, MTD or WST?
West Pharmaceutical Services, Inc. is larger by market capitalization — $23.6B versus $23.5B.
Which grows faster, MTD or WST?
Over the last five fiscal years, West Pharmaceutical Services, Inc. grew revenue faster — 7.4%/yr versus 5.5%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.